RXQ Compounding, backed by Ohio Innovation Fund, has added $3.6m in series A funding from Advantage Capital to its coffers.
RXQ Compounding, a US-based medical supplies provider backed by universities-backed venture capital firm Ohio Innovation Fund, received almost $3.6m in funding yesterday from VC firm Advantage Capital.
The figure included $1m invested under the government-run Ohio Rural Business Growth tax credit scheme, and an unspecified sum covered by the New Markets Tax Credit program, which channels investment into disadvantaged communities.
Founded in 2015, RXQ produces more than 160 pharmaceutical products that include injectables, veterinary medications, ophthalmic solutions and orthopaedic steroids,…
